Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model

Laboratory Investigation

Volumn 88, Issue 10, 2008, Pages 1079-1089

  Lin, Chiou Feng ^a   Wan, Shu Wen ^a   Chen, Mei Chun ^a   Lin, Shin Chao ^a   Cheng, Chu Chen ^a   Chiu, Shu Chen ^a   Hsiao, Yu Ling ^a   Lei, Huan Yao ^a   Liu, Hsiao Sheng ^a   Yeh, Trai Ming ^a   Lin, Yee Shin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Antibodies; Dengue virus; Liver injury; Mice; Nonstructural protein 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G; NONSTRUCTURAL PROTEIN 1; PROTEIN ANTIBODY;

ACTIVE IMMUNIZATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BINDING AFFINITY; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE MEDIATED INJURY; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BLOOD VESSEL; LIVER INJURY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PHAGOCYTE; PRIORITY JOURNAL; TISSUE SECTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; LIVER DISEASES; MALE; MICE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 52649172616     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.70     Document Type: Article

References (63)

1. Henchal EA, Putnak JB. The dengue viruses. Clin Microbiol Rev 1990;3:376-396.
2. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998;11:480-496.
3. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004;10:S98-S109.
4. Callaway E. Dengue fever climbs the social ladder. Nature 2007;448:734-735.
5. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988;239:476-481.
6. Halstead SB. Dengue. Curr Opin Infect Dis 2002;15:471-476.
7. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994;19:500-512.
8. Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 2003;60:421-467.
9. Mady BJ, Erbe DV, Kurane I, et al. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fcγ receptors. J Immunol 1991;147:3139-3144.
10. Huang KJ, Yang YC, Lin YS, et al. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol 2006;176:2825-2832.
11. Bielefeldt-Ohmann H. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol 1997;5:409-413.
12. Diamond MS, Edgil D, Roberts TG, et al. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 2000;74:7814-7823.
13. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.
14. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999;257:1-6.
15. Lei HY, Yeh TM, Liu HS, et al. Immunopathogenesis of dengue virus infection. J Biomed Sci 2001;8:377-388.
16. Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest 2004;113:946-951.
17. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006;19:429-436.
18. Clyde K, Kyle JL, Harris E. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 2006;80:11418-11431.
19. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003;9:921-927.
20. Halstead SB, Deen J. The future of dengue vaccines. Lancet 2002;360:1243-1245.
21. Pang T. Vaccines for the prevention of neglected diseases - dengue fever. Curr Opin Biotech 2003;14:332-336.
22. Edelman R, Wasserman SS, Bodison SA, et al. Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. Am J Trop Med Hyg 2003;69(Suppl 6):48-60.
23. Sabchareon A, Lang J, Chanthavanich P, et al. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. Pediatr Infect Dis J 2004;23:99-109.
24. Stephenson JR. Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ 2005;83:308-314.
25. Guirakhoo F, Kitchener S, Morrison D, et al. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine: phase I clinical trial for safety and immunogenicity. Effect of yellow fever preimmunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Hum Vaccin 2006;2:60-67.
26. Whitehead SS, Blaney JE, Durbin AP, et al. Prospects for a dengue virus vaccine. Nat Rev Microbiol 2007;5:518-528.
27. Kuo CH, Tai DI, Chang-Chien CS, et al. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992;47:265-270.
28. Nguyen TL, Nguyen TH, Tieu NT. The impact of dengue haemorrhagic fever on liver function. Res Virol 1997;148:273-277.
29. Pancharoen C, Rungsarannont A, Thisyakorn U. Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai 2002;85:S298-S301.
30. Lin YL, Liu CC, Lei HY, et al. Infection of five human liver cell lines by dengue-2 virus. J Med Virol 2000;60:425-431.
31. Lin YL, Liu CC, Chuang JI, et al. Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology 2000;276:114-126.
32. Marianneau P, Cardona A, Edelman L, et al. Dengue virus replication in human hepatoma cells activates NF-κB which in turn induces apoptotic cell death. J Virol 1997;71:3244-3249.
33. Thongtan T, Panyim S, Smith DR. Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol 2004;72:436-444.
34. Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-176.
35. Higuchi H, Gores GJ. Mechanisms of liver injury: an overview. Curr Mol Med 2003;3:483-490.
36. Falconar AKI. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 1997;142:897-916.
37. Lin CF, Lei HY, Shiau AL, et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol 2003;69:82-90.
38. Lin CF, Lei HY, Shiau AL, et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol 2002;169:657-664.
39. Lin YS, Lin CF, Lei HY, et al. Antibody-mediated endothelial cell damage via nitric oxide. Curr Pharm Des 2004;10:213-221.
40. Lin CF, Chiu SC, Hsiao YL, et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol 2005;174:395-403.
41. Lin CF, Wan SW, Cheng HJ, et al. Autoimmune pathogenesis in dengue virus infection. Viral Immunol 2006;19:127-132.
42. van Oosten M, van de Bilt E, de Vries HE, et al. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995;22:1538-1546.
43. Mochida S, Ohno A, Arai M, et al. Role of adhesion molecules in the development of massive hepatic necrosis in rats. Hepatology 1996;23:320-328.
44. Hung NT, Lei HY, Lan NT, et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 2004;189:221-232.
45. Couvelard A, Marianneau P, Bedel C, et al. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol 1999;30:1106-1110.
46. Fabre A, Couvelard A, Degott C, et al. Dengue virus induced hepatitis with chronic calcific changes. Gut 2001;49:864-865.
47. Wahid SF, Sanusi S, Zawawi MM, et al. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J Trop Med Public Health 2000;31:259-263.
48. Lima EQ, Gorayeb FS, Zanon JR, et al. Dengue haemorrhagic fever-induced acute kidney injury without hypotension, haemolysis or rhabdomyolysis. Nephrol Dial Transplant 2007;22:3322-3326.
49. Anderson R, Wang S, Osiowy C, et al. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 1997;71:4226-4232.
50. Huerre MR, Lan NT, Marianneau P, et al. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 2001;438:107-115.
51. Manns MP. Recent developments in autoimmune liver diseases. J Gastroenterol Hepatol 1997;12:S256-S271.
52. Manns MP, Obermayer-Straub P. Viral induction of autoimmunity: mechanisms and examples in hepatology. J Viral Hepatol 1997;4:42-47.
53. Hon WM, Lee KH, Khoo HE. Nitric oxide in liver diseases: friend, foe, or just passerby? Ann N Y Acad Sci 2002;962:275-295.
54. McNaughton L, Puttagunta P, Martinez-Cuesta MA, et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci USA 2002;99:17161-17166.
55. Wang JH, Redmond HP, Wu QD, et al. Nitric oxide mediates hepatocyte injury. Am J Physiol 1998;275:G1117-G1126.
56. D'Ambrosio SM, Gibson-D'Ambrosio RE, Brady T, et al. Mechanisms of nitric oxide-induced cytotoxicity in normal human hepatocytes. Environ Mol Mutagen 2001;37:46-54.
57. Lin CF, Lei HY, Liu CC, et al. Autoimmunity in dengue virus infection. Dengue Bull 2004;28:51-57.
58. Bente DA, Melkus MW, Garcia JV, et al. Dengue fever in humanized NOD/SCID mice. J Virol 2005;79:13797-13799.
59. An J, Kimura-Kuroda J, Hirabayashi Y, et al. Development of a novel mouse model for dengue virus infection. Virology 1999;263:70-77.
60. Huang KJ, Li SYJ, Chen SC, et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 2000;81:2177-2182.
61. Paes MV, Pinhao AT, Barreto DF, et al. Liver injury and viremia in mice infected with dengue-2 virus. Virology 2005;338:236-246.
62. Chen HC, Hofman FM, Kung JT, et al. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 2007;81:5518-5526.
63. Chen HC, Lai SY, Sung JM, et al. Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus. J Med Virol 2004;73:419-431.